Literature DB >> 7708116

Comparison of alpha 1A- and alpha 1B-adrenoceptor coupling to inositol phosphate formation in rat kidney.

R Büscher1, W Erdbrügger, T Philipp, O E Brodde, M C Michel.   

Abstract

We have compared the coupling mechanisms of rat renal alpha 1A- and alpha 1B-like adrenoceptors to inositol phosphate formation. The experiments were performed in parallel in native renal tissue preparations and in those where alpha 1B-adrenoceptors had been inactivated by treatment with 10 mumol/l chloroethylclonidine for 30 min at 37 degrees C; renal slices were used in most experiments but isolated renal cells were also used in some cases. The Ca2+ chelating agent, EGTA (5 mmol/l), reduced noradrenaline-stimulated inositol phosphate formation in native but enhanced it in chloroethylclonidine-treated renal slices. The inhibitory effect of EGTA was not mimicked by 100 nmol/l nifedipine. Inactivation of 87% of cellular Gi by 16-20 h treatment with 500 ng/ml pertussis toxin did not significantly affect noradrenaline-stimulated inositol phosphate formation in isolated renal cells but abolished the inhibitory effect of chloroethylclonidine. The adenylate cyclase activator, forskolin (20 mumol/l), inhibited noradrenaline-stimulated inositol phosphate formation in native and chloroethylclonidine-treated slices, and the inhibitory effects of chloroethylclonidine treatment and forskolin were additive. We conclude that in rat kidney inositol phosphate formation via alpha 1B-like adrenoceptors may involve the influx of extracellular Ca2+ and a pertussis toxin-sensitive G-protein but is insensitive to inhibition by forskolin. In contrast alpha 1A-like adrenoceptor-mediated inositol phosphate formation does not require the presence of extracellular Ca2+ or of Gi and is sensitive to inhibition by forskolin. In comparison to published data from other model systems we further conclude that the signaling mechanisms of alpha 1-adrenoceptor subtypes may depend on their cellular environment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7708116     DOI: 10.1007/bf00169362

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

1.  Alpha 1 B- but not alpha 1 A-adrenoceptors mediate inositol phosphate generation.

Authors:  M C Michel; G Hanft; G Gross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

Review 2.  Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.

Authors:  K P Minneman
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

3.  Alpha 1A and alpha 1B-adrenoceptors enhance inositol phosphate generation in rat renal cortex.

Authors:  M C Michel; R Büscher; T Philipp; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

4.  The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.

Authors:  C Forray; J A Bard; J M Wetzel; G Chiu; E Shapiro; R Tang; H Lepor; P R Hartig; R L Weinshank; T A Branchek
Journal:  Mol Pharmacol       Date:  1994-04       Impact factor: 4.436

5.  Alpha 1-adrenoceptors in parotid cells: age does not alter the ratio of alpha 1A and alpha 1B subtypes.

Authors:  R Villalobos-Molina; A Miyamoto; M A Kowatch; G S Roth
Journal:  Eur J Pharmacol       Date:  1992-06-05       Impact factor: 4.432

6.  Pertussis toxin inhibition of alpha 1-adrenergic or vasopressin-induced Ca2+ fluxes in rat liver. Selective inhibition of the alpha 1-adrenergic receptor-coupled metabolic activation.

Authors:  N Butta; E Urcelay; C González-Manchón; R Parrilla; M S Ayuso
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

7.  Comparison of cloned and pharmacologically defined rat tissue alpha 1-adrenoceptor subtypes.

Authors:  M C Michel; P A Insel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

8.  Tissue- and subunit-specific regulation of G-protein expression by hypo- and hyperthyroidism.

Authors:  M B Michel-Reher; G Gross; J R Jasper; D Bernstein; T Olbricht; O E Brodde; M C Michel
Journal:  Biochem Pharmacol       Date:  1993-04-06       Impact factor: 5.858

9.  Functional studies on alpha 1-adrenoceptor subtypes mediating inotropic effects in rat right ventricle.

Authors:  M C Michel; G Hanft; G Gross
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

10.  Competitive regulation of phospholipase C responses by cAMP and calcium.

Authors:  J B Schachter; J K Ivins; R N Pittman; B B Wolfe
Journal:  Mol Pharmacol       Date:  1992-03       Impact factor: 4.436

View more
  2 in total

1.  Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.

Authors:  H Chen; C Fetscher; R F Schäfers; G Wambach; T Philipp; M C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

2.  Endothelin-induced inositol phosphate formation in rat kidney. Studies on receptor subtypes, G-proteins and regulation during ontogenesis.

Authors:  K Becker; W Erdbrügger; I Heinroth-Hoffmann; M C Michel; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.